Search research articles
Contact Us
Filters
Showing results (11-20 of 42) with videos related to
Page
of 5
Sort By:
Vaccine
|
May 24, 2018
A phase 1 study of safety and immunogenicity following intradermal administration of a tetravalent dengue vaccine candidate
Lisa A Jackson, Richard Rupp, Athanasia Papadimitriou, et al.
Clinical Pediatrics
|
June 2, 2009
Factors associated with completion of the human papillomavirus vaccine series
Tara P L Neubrand, Carmen Radecki Breitkopf, Richard Rupp, et al.
Human Vaccines & Immunotherapeutics
|
October 10, 2018
Achieving high HPV vaccine completion rates in a pediatric clinic population
Abbey B Berenson, Richard Rupp, Erin E Dinehart, et al.
Vaccine
|
February 5, 2014
School-based vaccination of young US males: impact of health beliefs on intent and first dose acceptance
Vaughn I Rickert, Beth A Auslander, Dena S Cox, et al.
Phytopathology
|
October 10, 2013
Effect of climate on the distribution of Fusarium spp. causing crown rot of wheat in the Pacific Northwest of the United States
Grant J Poole, Richard W Smiley, Carl Walker, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine
|
August 20, 2008
Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccine attitudes
Susan L Rosenthal, Richard Rupp, Gregory D Zimet, et al.
Plant Disease
|
February 3, 2019
Relationship Between Climatic Factors and Distribution of Pratylenchus spp. in the Dryland Wheat-Production Areas of Eastern Washington
Shyam L Kandel, Richard W Smiley, Kimberly Garland-Campbell, et al.
Vaccine
|
February 15, 2024
Safety, tolerability and immunogenicity of a novel 24-valent pneumococcal vaccine in toddlers: A phase 1 randomized controlled trial
Dorota Borys, Richard Rupp, Ronald Smulders, et al.
Vaccine
|
September 20, 2015
Safety and immunogenicity of different doses and schedules of a live attenuated tetravalent dengue vaccine (TDV) in healthy adults: A Phase 1b randomized study
Richard Rupp, Gary Joseph Luckasen, Judith Lee Kirstein, et al.
The Journal of Infectious Diseases
|
May 27, 2017
Six-Month Safety Data of Recombinant Vesicular Stomatitis Virus-Zaire Ebola Virus Envelope Glycoprotein Vaccine in a Phase 3 Double-Blind, Placebo-Controlled Randomized Study in Healthy Adults
Scott A Halperin, Jose R Arribas, Richard Rupp, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 42) with videos related to
Sort By:
Page
of 5
Vaccine
|
May 24, 2018
A phase 1 study of safety and immunogenicity following intradermal administration of a tetravalent dengue vaccine candidate
Lisa A Jackson, Richard Rupp, Athanasia Papadimitriou, et al.
Clinical Pediatrics
|
June 2, 2009
Factors associated with completion of the human papillomavirus vaccine series
Tara P L Neubrand, Carmen Radecki Breitkopf, Richard Rupp, et al.
Human Vaccines & Immunotherapeutics
|
October 10, 2018
Achieving high HPV vaccine completion rates in a pediatric clinic population
Abbey B Berenson, Richard Rupp, Erin E Dinehart, et al.
Vaccine
|
February 5, 2014
School-based vaccination of young US males: impact of health beliefs on intent and first dose acceptance
Vaughn I Rickert, Beth A Auslander, Dena S Cox, et al.
Phytopathology
|
October 10, 2013
Effect of climate on the distribution of Fusarium spp. causing crown rot of wheat in the Pacific Northwest of the United States
Grant J Poole, Richard W Smiley, Carl Walker, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine
|
August 20, 2008
Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccine attitudes
Susan L Rosenthal, Richard Rupp, Gregory D Zimet, et al.
Plant Disease
|
February 3, 2019
Relationship Between Climatic Factors and Distribution of Pratylenchus spp. in the Dryland Wheat-Production Areas of Eastern Washington
Shyam L Kandel, Richard W Smiley, Kimberly Garland-Campbell, et al.
Vaccine
|
February 15, 2024
Safety, tolerability and immunogenicity of a novel 24-valent pneumococcal vaccine in toddlers: A phase 1 randomized controlled trial
Dorota Borys, Richard Rupp, Ronald Smulders, et al.
Vaccine
|
September 20, 2015
Safety and immunogenicity of different doses and schedules of a live attenuated tetravalent dengue vaccine (TDV) in healthy adults: A Phase 1b randomized study
Richard Rupp, Gary Joseph Luckasen, Judith Lee Kirstein, et al.
The Journal of Infectious Diseases
|
May 27, 2017
Six-Month Safety Data of Recombinant Vesicular Stomatitis Virus-Zaire Ebola Virus Envelope Glycoprotein Vaccine in a Phase 3 Double-Blind, Placebo-Controlled Randomized Study in Healthy Adults
Scott A Halperin, Jose R Arribas, Richard Rupp, et al.
Page
of 5